nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—pes—leprosy	0.117	0.249	CbGeAlD
Pemetrexed—ATIC—hindlimb—leprosy	0.0532	0.113	CbGeAlD
Pemetrexed—ATIC—appendage—leprosy	0.0456	0.0971	CbGeAlD
Pemetrexed—ATIC—skin epidermis—leprosy	0.0379	0.0808	CbGeAlD
Pemetrexed—Creatinine low—Thalidomide—leprosy	0.0328	0.0645	CcSEcCtD
Pemetrexed—Mood alteration NOS—Thalidomide—leprosy	0.0314	0.0616	CcSEcCtD
Pemetrexed—Blood creatinine decreased—Thalidomide—leprosy	0.03	0.059	CcSEcCtD
Pemetrexed—Peripheral sensory neuropathy—Thalidomide—leprosy	0.022	0.0433	CcSEcCtD
Pemetrexed—GART—eye—leprosy	0.0199	0.0424	CbGeAlD
Pemetrexed—SLC46A1—eye—leprosy	0.0161	0.0344	CbGeAlD
Pemetrexed—Intestinal perforation—Thalidomide—leprosy	0.0159	0.0313	CcSEcCtD
Pemetrexed—ATIC—eye—leprosy	0.0135	0.0288	CbGeAlD
Pemetrexed—GART—tendon—leprosy	0.0132	0.0281	CbGeAlD
Pemetrexed—White blood cell count decreased—Thalidomide—leprosy	0.0127	0.0249	CcSEcCtD
Pemetrexed—Transient ischaemic attack—Thalidomide—leprosy	0.0125	0.0245	CcSEcCtD
Pemetrexed—DCK—Menadione—Thalidomide—leprosy	0.0121	0.571	CbGdCrCtD
Pemetrexed—ATIC—skin of body—leprosy	0.0118	0.025	CbGeAlD
Pemetrexed—Skin exfoliation—Dapsone—leprosy	0.0117	0.0231	CcSEcCtD
Pemetrexed—GART—testis—leprosy	0.0109	0.0232	CbGeAlD
Pemetrexed—GART—nervous system—leprosy	0.0107	0.0228	CbGeAlD
Pemetrexed—SLC46A1—tendon—leprosy	0.0107	0.0228	CbGeAlD
Pemetrexed—Platelet count decreased—Thalidomide—leprosy	0.0106	0.0208	CcSEcCtD
Pemetrexed—Febrile neutropenia—Thalidomide—leprosy	0.0105	0.0206	CcSEcCtD
Pemetrexed—Embolism—Thalidomide—leprosy	0.00981	0.0193	CcSEcCtD
Pemetrexed—TYMS—Menadione—Thalidomide—leprosy	0.00915	0.43	CbGdCrCtD
Pemetrexed—DHFR—eye—leprosy	0.00907	0.0193	CbGeAlD
Pemetrexed—Thrombosis—Thalidomide—leprosy	0.0089	0.0175	CcSEcCtD
Pemetrexed—Interstitial lung disease—Thalidomide—leprosy	0.0089	0.0175	CcSEcCtD
Pemetrexed—SLC46A1—testis—leprosy	0.00886	0.0189	CbGeAlD
Pemetrexed—SLC46A1—nervous system—leprosy	0.00869	0.0185	CbGeAlD
Pemetrexed—Neuritis—Thalidomide—leprosy	0.00843	0.0166	CcSEcCtD
Pemetrexed—TYMS—skin of body—leprosy	0.00797	0.017	CbGeAlD
Pemetrexed—Myocardial ischaemia—Thalidomide—leprosy	0.00783	0.0154	CcSEcCtD
Pemetrexed—Pancreatitis—Dapsone—leprosy	0.00757	0.0149	CcSEcCtD
Pemetrexed—ATIC—testis—leprosy	0.00741	0.0158	CbGeAlD
Pemetrexed—ATIC—nervous system—leprosy	0.00727	0.0155	CbGeAlD
Pemetrexed—Neuropathy peripheral—Dapsone—leprosy	0.00674	0.0132	CcSEcCtD
Pemetrexed—Creatinine increased—Thalidomide—leprosy	0.00661	0.013	CcSEcCtD
Pemetrexed—Pulmonary embolism—Thalidomide—leprosy	0.0063	0.0124	CcSEcCtD
Pemetrexed—Pharyngitis—Dapsone—leprosy	0.00613	0.012	CcSEcCtD
Pemetrexed—TYMS—tendon—leprosy	0.00607	0.0129	CbGeAlD
Pemetrexed—Colitis—Thalidomide—leprosy	0.00605	0.0119	CcSEcCtD
Pemetrexed—Skin exfoliation—Thalidomide—leprosy	0.00601	0.0118	CcSEcCtD
Pemetrexed—DHFR—tendon—leprosy	0.00601	0.0128	CbGeAlD
Pemetrexed—Neuropathy—Thalidomide—leprosy	0.00591	0.0116	CcSEcCtD
Pemetrexed—Oesophagitis—Thalidomide—leprosy	0.00575	0.0113	CcSEcCtD
Pemetrexed—Sepsis—Thalidomide—leprosy	0.00546	0.0107	CcSEcCtD
Pemetrexed—SLC29A1—tendon—leprosy	0.00544	0.0116	CbGeAlD
Pemetrexed—Erythema—Dapsone—leprosy	0.00538	0.0106	CcSEcCtD
Pemetrexed—DCK—tendon—leprosy	0.0052	0.0111	CbGeAlD
Pemetrexed—TYMS—testis—leprosy	0.00502	0.0107	CbGeAlD
Pemetrexed—DHFR—testis—leprosy	0.00497	0.0106	CbGeAlD
Pemetrexed—Renal failure acute—Thalidomide—leprosy	0.00495	0.00972	CcSEcCtD
Pemetrexed—TYMS—nervous system—leprosy	0.00493	0.0105	CbGeAlD
Pemetrexed—DHFR—nervous system—leprosy	0.00488	0.0104	CbGeAlD
Pemetrexed—Cerebrovascular accident—Thalidomide—leprosy	0.00466	0.00916	CcSEcCtD
Pemetrexed—SLC29A1—testis—leprosy	0.00451	0.00959	CbGeAlD
Pemetrexed—SLC29A1—nervous system—leprosy	0.00442	0.00942	CbGeAlD
Pemetrexed—Mood swings—Thalidomide—leprosy	0.00433	0.0085	CcSEcCtD
Pemetrexed—DCK—testis—leprosy	0.0043	0.00917	CbGeAlD
Pemetrexed—Blood creatinine increased—Thalidomide—leprosy	0.00428	0.00841	CcSEcCtD
Pemetrexed—Dehydration—Thalidomide—leprosy	0.00425	0.00835	CcSEcCtD
Pemetrexed—DCK—nervous system—leprosy	0.00422	0.009	CbGeAlD
Pemetrexed—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00412	0.00808	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00412	0.00808	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Thalidomide—leprosy	0.00403	0.00792	CcSEcCtD
Pemetrexed—Dysphagia—Thalidomide—leprosy	0.00395	0.00776	CcSEcCtD
Pemetrexed—Pancreatitis—Thalidomide—leprosy	0.00387	0.00761	CcSEcCtD
Pemetrexed—Angina pectoris—Thalidomide—leprosy	0.00385	0.00756	CcSEcCtD
Pemetrexed—Pancytopenia—Thalidomide—leprosy	0.00375	0.00737	CcSEcCtD
Pemetrexed—Neutropenia—Thalidomide—leprosy	0.00369	0.00725	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dapsone—leprosy	0.00359	0.00705	CcSEcCtD
Pemetrexed—Infestation—Thalidomide—leprosy	0.00352	0.00692	CcSEcCtD
Pemetrexed—Infestation NOS—Thalidomide—leprosy	0.00352	0.00692	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00349	0.00686	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Thalidomide—leprosy	0.00347	0.00682	CcSEcCtD
Pemetrexed—Body temperature increased—Dapsone—leprosy	0.00347	0.00681	CcSEcCtD
Pemetrexed—Abdominal pain—Dapsone—leprosy	0.00347	0.00681	CcSEcCtD
Pemetrexed—Renal failure—Thalidomide—leprosy	0.00346	0.0068	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Thalidomide—leprosy	0.00345	0.00678	CcSEcCtD
Pemetrexed—Myocardial infarction—Thalidomide—leprosy	0.00345	0.00678	CcSEcCtD
Pemetrexed—Stomatitis—Thalidomide—leprosy	0.00343	0.00674	CcSEcCtD
Pemetrexed—Conjunctivitis—Thalidomide—leprosy	0.00342	0.00672	CcSEcCtD
Pemetrexed—Agranulocytosis—Thalidomide—leprosy	0.00329	0.00646	CcSEcCtD
Pemetrexed—Hepatitis—Thalidomide—leprosy	0.00316	0.00621	CcSEcCtD
Pemetrexed—Pharyngitis—Thalidomide—leprosy	0.00314	0.00616	CcSEcCtD
Pemetrexed—Urinary tract disorder—Thalidomide—leprosy	0.00312	0.00613	CcSEcCtD
Pemetrexed—Urethral disorder—Thalidomide—leprosy	0.0031	0.00609	CcSEcCtD
Pemetrexed—Erythema multiforme—Thalidomide—leprosy	0.00299	0.00587	CcSEcCtD
Pemetrexed—Eye disorder—Thalidomide—leprosy	0.00295	0.0058	CcSEcCtD
Pemetrexed—Arrhythmia—Thalidomide—leprosy	0.00282	0.00555	CcSEcCtD
Pemetrexed—Alopecia—Thalidomide—leprosy	0.00279	0.00549	CcSEcCtD
Pemetrexed—Vomiting—Dapsone—leprosy	0.00279	0.00548	CcSEcCtD
Pemetrexed—Malnutrition—Thalidomide—leprosy	0.00275	0.00541	CcSEcCtD
Pemetrexed—Dysgeusia—Thalidomide—leprosy	0.0027	0.00529	CcSEcCtD
Pemetrexed—Nausea—Dapsone—leprosy	0.00261	0.00512	CcSEcCtD
Pemetrexed—Anaemia—Thalidomide—leprosy	0.00254	0.005	CcSEcCtD
Pemetrexed—Syncope—Thalidomide—leprosy	0.00247	0.00485	CcSEcCtD
Pemetrexed—Leukopenia—Thalidomide—leprosy	0.00246	0.00484	CcSEcCtD
Pemetrexed—Loss of consciousness—Thalidomide—leprosy	0.00242	0.00475	CcSEcCtD
Pemetrexed—Hypertension—Thalidomide—leprosy	0.00238	0.00467	CcSEcCtD
Pemetrexed—Chest pain—Thalidomide—leprosy	0.00234	0.0046	CcSEcCtD
Pemetrexed—Myalgia—Thalidomide—leprosy	0.00234	0.0046	CcSEcCtD
Pemetrexed—Arthralgia—Thalidomide—leprosy	0.00234	0.0046	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00233	0.00457	CcSEcCtD
Pemetrexed—Oedema—Thalidomide—leprosy	0.00225	0.00441	CcSEcCtD
Pemetrexed—Infection—Thalidomide—leprosy	0.00223	0.00438	CcSEcCtD
Pemetrexed—Shock—Thalidomide—leprosy	0.00221	0.00434	CcSEcCtD
Pemetrexed—Nervous system disorder—Thalidomide—leprosy	0.0022	0.00433	CcSEcCtD
Pemetrexed—Thrombocytopenia—Thalidomide—leprosy	0.0022	0.00432	CcSEcCtD
Pemetrexed—Skin disorder—Thalidomide—leprosy	0.00218	0.00429	CcSEcCtD
Pemetrexed—Anorexia—Thalidomide—leprosy	0.00214	0.00421	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Thalidomide—leprosy	0.00205	0.00402	CcSEcCtD
Pemetrexed—Dyspnoea—Thalidomide—leprosy	0.002	0.00393	CcSEcCtD
Pemetrexed—Dyspepsia—Thalidomide—leprosy	0.00198	0.00388	CcSEcCtD
Pemetrexed—Decreased appetite—Thalidomide—leprosy	0.00195	0.00384	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Thalidomide—leprosy	0.00194	0.00381	CcSEcCtD
Pemetrexed—Fatigue—Thalidomide—leprosy	0.00194	0.0038	CcSEcCtD
Pemetrexed—Constipation—Thalidomide—leprosy	0.00192	0.00377	CcSEcCtD
Pemetrexed—Pain—Thalidomide—leprosy	0.00192	0.00377	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Thalidomide—leprosy	0.00184	0.00361	CcSEcCtD
Pemetrexed—Urticaria—Thalidomide—leprosy	0.00178	0.0035	CcSEcCtD
Pemetrexed—Abdominal pain—Thalidomide—leprosy	0.00178	0.00349	CcSEcCtD
Pemetrexed—Body temperature increased—Thalidomide—leprosy	0.00178	0.00349	CcSEcCtD
Pemetrexed—Hypersensitivity—Thalidomide—leprosy	0.00166	0.00325	CcSEcCtD
Pemetrexed—Asthenia—Thalidomide—leprosy	0.00161	0.00317	CcSEcCtD
Pemetrexed—Pruritus—Thalidomide—leprosy	0.00159	0.00312	CcSEcCtD
Pemetrexed—Diarrhoea—Thalidomide—leprosy	0.00154	0.00302	CcSEcCtD
Pemetrexed—Dizziness—Thalidomide—leprosy	0.00149	0.00292	CcSEcCtD
Pemetrexed—Vomiting—Thalidomide—leprosy	0.00143	0.00281	CcSEcCtD
Pemetrexed—Rash—Thalidomide—leprosy	0.00142	0.00278	CcSEcCtD
Pemetrexed—Dermatitis—Thalidomide—leprosy	0.00142	0.00278	CcSEcCtD
Pemetrexed—Nausea—Thalidomide—leprosy	0.00133	0.00262	CcSEcCtD
